EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma

Oncologist. 2018 Jul;23(7):870. doi: 10.1634/theoncologist.2017-0301erratum.
No abstract available

Publication types

  • Published Erratum